Home Complaints database Transparency International Germany vs. Ratiopharm
Complaint

Transparency International Germany vs. Ratiopharm

Ratiopharm’s unethical marketing in Germany, Belgium et al

Date filed
20 April 2006
Keywords
Countries of harm
Current status
Rejected
Sector
NCP

Allegations

Ratiopharm, a pharmaceuticals company and major producer of generic drugs, has allegedly engaged in unethical marketing practices, including bribing doctors and pharmacists in Belgium, Canada, Spain, Estonia and Germany.

Relevant OECD Guidelines

Outcome

In June 2006, the German NCP rejected the complaint citing the lack of transnational investment. Specifically, the NCP stated the complaint only dealt with alleged misbehaviour in Germany. In July 2006, Transparency International Germany resubmitted a revised and expanded complaint

More details

Defendant
Company in violation
Complainants
Affected people
Date rejected / concluded
27 June 2006

Related complaints

Documents

  • file
    18 July 2006

    TI submits revised and expanded complaint (see: Transparency International - Germany vs. Ratiopharm refile).

    Transparency International Germany
  • file
    20 April 2006

    Complaint submitted to German NCP.

    Transparency International Germany